Randolph Charles joins Elsevier
Named Executive Vice President/Chief Marketing Officer for the company’s Health Sciences Division.
Philadelphia, March 30, 2005 - Elsevier is pleased to announce that Randolph Charles has recently joined the company, in the capacity of Executive Vice President/Chief Marketing Officer, for Elsevier’s Health Sciences Division. Mr. Charles will be responsible for all Health Sciences marketing, as well as Elsevier Canada. He will be part of the Health Sciences Division Management Group and will be based in Philadelphia, where the division is headquartered.
Mr. Charles comes to Elsevier with a wide range of marketing experience. Most recently, he served as Senior Vice President, Customer Relationship Marketing at Rodale, Inc. where he developed and drove change to CRM approaches from traditional direct mail marketing. Earlier, Mr. Charles held a variety of increasingly responsible sales and marketing positions at the Times Mirror Corporation, including Vice President of Marketing and New Business Development for Newsday, Inc.; Vice President, Sales and Marketing for Mosby Matthew Bender; and Senior Vice President for Consumer Marketing and President of the Marine Group, Times Mirror Magazines.
“I am excited to be back in health sciences publishing, and particularly with Elsevier, a world leader,” declared Mr. Charles. “I look forward to the challenge of enhancing the role of marketing in developing new and innovative print and on-line products that meet the changing needs of health care professionals."
Mr. Charles began his career as a consultant with McKinsey & Company where he worked primarily with media and information companies. He holds a bachelor’s degree from Yale University, where he graduated summa cum laude and was elected to Phi Beta Kappa, and an M.B.A. from Harvard University, where he was a Baker Scholar.
“Randy is a true marketing professional,” commented Brian Nairn, CEO of Elsevier’s Health Sciences division. “He brings us broad expertise in diversified market segments and a great track record in new business development for both print and on-line products. We are delighted to have Randy on board and look forward to benefiting from his world-class capabilities.”
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).